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Parp1 hyperactivity couples DNA breaks
to aberrant neuronal calcium signalling and
lethal seizures
Emilia Komulainen1, Jack Badman1,2, Stephanie Rey2, Stuart Rulten1, Limei Ju1, Kate Fennell2,
Ilona Kalasova3 , Kristyna Ilievova3, Peter J McKinnon4 , Hana Hanzlikova1,3 , Kevin Staras2,* &
Keith W Caldecott1,3,**
Abstract
Defects in DNA single-strand break repair (SSBR) are linked with
neurological dysfunction but the underlying mechanisms remain
poorly understood. Here, we show that hyperactivity of the DNA
strand break sensor protein Parp1 in mice in which the central
SSBR protein Xrcc1 is conditionally deleted (Xrcc1Nes-Cre) results in
lethal seizures and shortened lifespan. Using electrophysiological
recording and synaptic imaging approaches, we demonstrate that
aberrant Parp1 activation triggers seizure-like activity in Xrcc1-
defective hippocampus ex vivo and deregulated presynaptic
calcium signalling in isolated hippocampal neurons in vitro. More-
over, we show that these defects are prevented by Parp1 inhibition
or deletion and, in the case of Parp1 deletion, that the lifespan of
Xrcc1Nes-Cre mice is greatly extended. This is the first demonstration
that lethal seizures can be triggered by aberrant Parp1 activity at
unrepaired SSBs, highlighting PARP inhibition as a possible thera-
peutic approach in hereditary neurological disease.
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Introduction
DNA single-strand breaks (SSBs) are the commonest DNA lesions
arising in cells and are rapidly detected by poly(ADP-ribose) poly-
merase-1 (PARP1) and/or poly(ADP-ribose) polymerase-2 (PARP2),
enzymes that are activated at DNA breaks and modify themselves
and other proteins with mono-ADP-ribose and/or poly-ADP-ribose
(Benjamin & Gill, 1980; Chaudhuri & Nussenzweig, 2017; Hanzlikova
et al, 2017; Azarm & Smith, 2020). Poly(ADP-ribose) triggers recruit-
ment of the DNA single-strand break repair (SSBR) scaffold protein
XRCC1 and its protein partners to facilitate the repair of SSBs (Breslin
et al, 2015; Hanzlikova et al, 2017; Caldecott, 2019). If not repaired
rapidly, SSBs can result in replication fork stalling and/or collapse
and can block the progression of RNA polymerases during gene tran-
scription (Hsiang et al, 1989; Ryan et al, 1991; Zhou & Doetsch, 1993;
Kuzminov, 2001; Kathe et al, 2004). Notably, mutations in proteins
involved in SSBR in humans are associated with cerebellar ataxia,
neurodevelopmental defects and episodic seizures (Caldecott, 2008;
Yoon & Caldecott, 2018). To date, all identified SSBR-defective
human diseases are mutated in either XRCC1 or one of its protein
partners (Caldecott, 2019).
Recently, we demonstrated using an Xrcc1-defective mouse
model (Xrcc1Nes-Cre) that SSBR-defective cerebellum possesses
elevated steady-state levels of poly(ADP-ribose) resulting from the
hyperactivation of Parp1, leading to the loss of cerebellar interneu-
rons and cerebellar ataxia (Lee et al, 2009; Hoch et al, 2017). PARP1
hyperactivity can trigger cellular dysfunction and/or cytotoxicity by
several mechanisms including excessive depletion of NAD+/ATP
and/or by generating excessive amounts of poly(ADP-ribose)
(Zhang et al, 1994; Andrabi et al, 2006; Yu et al, 2006; Andrabi
et al, 2014). However, the extent to which Parp1 hyperactivation
might account for the spectrum of neurological pathology induced
by unrepaired endogenous SSBs is unknown. Here, we have
addressed this question. We show that aberrant Parp1 activity
extends beyond the cerebellum in Xrcc1Nes-Cre mice and is evident
across the brain, resulting in deregulated neuronal presynaptic
calcium signalling, lethal seizures and shortened lifespan. Impor-
tantly, we demonstrate that Parp1 inhibition or deletion prevents
the Ca2+ signalling defects and elevated seizure-like activity in
Xrcc1Nes-Cre hippocampus and that Parp1 deletion prolongs the
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lifespan of Xrcc1Nes-Cre mice. These findings highlight the potential
of Parp1 as a target in the therapeutic treatment of XRCC1-defective
disease.
Results
Parp1 is hyperactive throughout Xrcc1Nes-Cre brain
We reported previously that Parp1 is hyperactive in the cerebellum
of Xrcc1Nes-Cre mice, resulting in cerebellar ataxia (Hoch et al, 2017).
Here, to extend this, we measured the steady-state level of pan-
ADP-ribose signal across Xrcc1-defective brain by immunohisto-
chemistry. We detected increased levels of ADP-ribose throughout
Xrcc1Nes-Cre brain, including the cortex, with particularly strong
immunostaining in the cerebellum and hippocampus (Fig 1A). In
contrast, we did not detect elevated levels of Atm protein, an unre-
lated DNA repair-associated antigen, ruling out that the elevated
anti-ADP-ribose signal was a non-specific artefact (Fig EV1). Indeed,
we confirmed that the elevated ADP-ribose signal was the product of
endogenous Parp1 activity, because Parp1 deletion in Xrcc1Nes-Cre
mice reduced this signal to levels below those in wild-type brain
(Fig 1A; Parp1//Xrcc1Nes-Cre). Consistent with this, the elevated
ADP-ribose signal in Xrcc1Nes-Cre brain was also detected if we
employed antibody specific for poly(ADP-ribose), which is the
primary ADP-ribosylation product of Parp1 activity (Fig EV1).
To examine whether we could recapitulate the increased ADP-
ribosylation in Xrcc1Nes-Cre brain biochemically, we incubated tissue
extracts from wild-type and Xrcc1Nes-Cre forebrain, containing cortex
and hippocampus, with NAD+ to stimulate ADP-ribosylation
in vitro. Indeed, wild-type but not Parp1/ forebrain extracts
rapidly accumulated ADP-ribosylated proteins when incubated with
NAD+ (Fig 1B). More importantly, tissue extracts prepared from
Xrcc1Nes-Cre forebrain accumulated ADP-ribosylated proteins more
rapidly and to a greater extent than did wild-type extracts, and
similar results were observed if we employed tissue extracts from
cerebellum (Fig 1B and C). Consistent with ongoing Parp1 hyperac-
tivity, the steady-state level of NAD+ in Xrcc1Nes-Cre forebrain was
half that present in wild-type forebrain and was increased by dele-
tion of even a single Parp1 allele (Fig 1D). Collectively, these data
implicate widespread Parp1 hyperactivation in Xrcc1-defective
brain, presumably as a result of the underlying defect in SSB repair
(Lee et al, 2009). In agreement with this, we did not detect elevated
ADP-ribose in brain from Ku70/ mice in which the primary path-
way for DNA double-strand break (DSB) repair in brain is defective,
confirming that the elevated ADP-ribose in Xrcc1Nes-cre brain was the
result of unrepaired SSBs, not DSBs (Fig 1A).
Parp1 hyperactivation triggers juvenile seizures and mortality in
Xrcc1Nes-Cre mice
Next, we generated Kaplan–Meier survival curves to determine the
influence of Xrcc1 on lifespan. As expected (Lee et al, 2009),
Xrcc1Nes-Cre animals exhibited greatly reduced longevity when
compared to wild-type mice, with the cohort employed in these
experiments having a median lifespan of ~ 3–4 weeks (Fig 2A).
Given the widespread Parp1 hyperactivity across the brain in
Xrcc1Nes-Cre mice, we examined the impact of Parp1 deletion on
lifespan. Remarkably, the median lifespan of Parp1+/-/Xrcc1Nes-Cre
and Parp//Xrcc1Nes-Cre littermates in which one or both Parp1 alle-
les were additionally deleted was increased ~ 25-fold and ~ 7-fold,
to 79 and 23 weeks, respectively (Fig 2A). This result demonstrates
that aberrant Parp1 activity in Xrcc1-defective brain is a major
contributor to organismal death. It is noteworthy that deletion of one
Parp1 allele prolonged the lifespan of Xrcc1Nes-Cre mice to a greater
extent than deletion of both Parp1 alleles. This suggests that whilst
the loss of a single Parp1 allele is sufficient to suppress Parp1-
induced toxicity, the loss of the second allele eradicates an additional
role for Parp1 in Xrcc1-defective brain that is important for survival.
Next, to establish the cause of Parp1-dependent death in
Xrcc1Nes-Cre mice, we conducted infrared video imaging for a four-
day period starting at P15. These experiments revealed that
Xrcc1Nes-Cre mice experienced sporadic seizures, culminating ulti-
mately in a lethal seizure from which animals did not recover
(Fig 2B). In contrast, we did not observe any seizures in wild-type
mice over the same time period. The cause of death induced by the
seizures is unclear but, similar to sudden unexpected death during
epilepsy (SUDEP) in humans, it is likely to result from the disrup-
tion of normal cardiac or respiratory function (Surges et al, 2009).
Importantly, we also did not detect seizures in Xrcc1Nes-Cre mice in
which one or both alleles of Parp1 were deleted over the time course
of the experiment, consistent with the increased lifespan of these
mice (Fig 2B). To our knowledge, this is the first demonstration that
seizures can be triggered by aberrant Parp1 activity.
Seizure-like activity in Xrcc1Nes-Cre brain slices is corrected by
Parp1 deletion
The induction of seizures by Parp1 in Xrcc1Nes-Cre mice is consistent
with the strikingly high level of poly(ADP-ribose) in the hippocam-
pus of these animals, because defects in this region of the brain are
often associated with seizure activity (Gunn & Baram, 2017). To
examine directly whether elevated seizure-like activity is present in
Xrcc1Nes-Cre hippocampus, we carried out targeted extracellular elec-
trophysiological recording experiments in brain slices prepared from
wild-type mice, Xrcc1Nes-Cre mice and Xrcc1Nes-Cre mice in which
Parp1 was additionally deleted. When the brain slices were washed
into an epileptogenic solution, the mean cumulative number of
seizure-like events in the CA3 region of Xrcc1Nes-Cre hippocampus
was ~ 2.5-fold greater than in wild-type hippocampus (Fig 3A–C).
Moreover, strikingly, this elevated seizure-like activity was reduced
or prevented if one or both alleles of Parp1 were deleted, respec-
tively (Fig 3A–C), confirming Parp1 as the cause of the elevated
seizure activity in Xrcc1/ hippocampus.
To extend these analyses, we employed a high-density multi-
electrode array (HD-MEA) platform (Fig 4A). This approach allowed
us to assay the spatial organization of network activity across
hippocampal and cortical structures simultaneously and with high
temporal resolution. In particular, we recorded the onset and thresh-
old of seizure-like events in the cortex, CA1 and CA3 regions of
brain slices perfused into an epileptogenic solution, and plotted the
cumulative activity in each. In agreement with the results described
above, we found that seizure-like events were significantly higher in
Xrcc1Nes-Cre cortex and hippocampus when compared to wild type,
with the strongest effects observed in the hippocampal CA3 region
(Fig 4B–D).
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Given the ability of Parp1 deletion to rescue normal levels of
seizure-like activity in Xrcc1Nes-Cre brain, we extended these experi-
ments to examine the impact of PARP1 inhibitor. To do this, we
administered PARP1 inhibitor (ABT-888; veliparib) ad libitum in the
drinking water from day 10 until their analysis at days 14–17. Strik-
ingly, whereas this application of PARP1 inhibitor had little effect
on the seizure-like activity of brain sections prepared from wild-type
mice, it ablated the elevated seizure-like activity in Xrcc1Nes-Cre brain
slices, in all three regions of the brain tested (Fig 4E). Together,
these data confirm that Parp1 hyperactivity in Xrcc1Nes-Cre brain trig-
gers increased seizure-like activity that can be prevented by Parp1
deletion or pharmacological inhibition.
Aberrant Parp1 activity deregulates presynaptic calcium
signalling in Xrcc1Nes-Cre neurons
It is currently unclear how aberrant Parp1 activity at unrepaired





Figure 1. Hyperactivity of Parp1 in Xrcc1Nes-Cre brain.
A Sagittal sections obtained from mice (p15) of the indicated genotypes were immunostained for ADP-ribose using the pan-ADP-ribose detection reagent MABE1016.
Representative images showing levels of ADP-ribose in the hippocampal regions CA1, CA3 and dentate gyrus (DG), and in the cerebral cortex. Red dotted boxes
highlight the elevated ADP-ribose staining in Xrcc1Nes-Cre cerebellum (left dotted box) and hippocampus (right doted box). Scale bars: 5 mm, 50 lm. WT (n = 4 mice),
Xrcc1Nes-Cre (n = 4), Parp1+/- /Xrcc1Nes-Cre (n = 4), Parp1//Xrcc1Nes-Cre (n = 3) and Parp1/ (n = 3). Summary histograms show mean  SEM. Pairwise comparisons
between WT versus Xrcc1Nes-Cre mice and WT versus Parp1//Xrcc1Nes-Cre mice were conducted by Kruskal–Wallis ANOVA with Dunn’s post hoc test, and statistically
significant differences (*P < 0.05) are shown.
B Protein extracts from wild-type (WT), Xrcc1Nes-Cre and Parp1/ forebrain tissue, containing hippocampus and cortex, were incubated with 1 mM NAD+ for 45 min in
the presence or absence of PARP inhibitor as indicated, and ADP-ribosylation detected by Western blotting using the poly(ADP-ribose)-specific detection reagent
MABE1031. Representative images from two or more independent experiments are shown. A Western blot showing the level of Parp1 and Xrcc1 in the forebrain
tissue extracts is also shown, Inset.
C Protein extracts from wild-type (WT) and Xrcc1Nes-Cre forebrain or cerebellum were incubated for 0, 5, 10, 15, 30 and 45 min in the presence of NAD+ as above.
D NAD+ levels in wild-type (WT), Xrcc1Nes-Cre and Parp+/-/Xrcc1Nes-Cre forebrain tissue. Data are the scatterplots of individual measurements from at least three mice per
genotype, with error bars representing the mean  SEM. Statistically significant differences with Xrcc1Nes-cre are indicated (Kruskal–Wallis ANOVA with Dunn’s post
hoc test *P < 0.05).
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activity can affect the expression of many genes that might influence
seizure activity, including those affecting Ca2+ homeostasis (Stoyas
et al, 2019). Consequently, we examined whether the seizure-like
activity in Xrcc1Nes-Cre mice reflects a defect in Ca2+ signalling at the
level of single synapses in isolated hippocampal neurons. Similar to
whole brain sections, we detected elevated endogenous levels of
ADP-ribosylation in isolated Xrcc1Nes-Cre neurons, although as
observed previously in other cultured cell types (Hanzlikova et al,
2018) the detection of endogenous poly(ADP-ribose) required incu-
bation for 1 h with an inhibitor of poly(ADP-ribose) glycohydrolase
A B
Figure 2. Parp1 hyperactivation triggers juvenile seizures and mortality in the absence of Xrcc1.
A Kaplan–Meier curves for survival of mice of the indicated genotypes. The table shows number of individuals in each group, median survival (weeks) and P-values from
pairwise curve comparisons; Und: undetermined (log-rank Mantel–Cox tests).
B Video monitoring and recording of generalized running/bouncing seizures in mice of the indicated genotypes from P15-P19. The point of death of Xrcc1Nes-Cre mice by
fatal seizure is indicated (cross). Note no seizures from mice of other genotypes were detected. WT (n = 9 mice), Xrcc1Nes-cre (n = 3 mice), Parp1+//Xrcc1Nes-Cre (n = 3
mice) and Parp1//Xrcc1Nes-Cre (n = 3).
A
B C
Figure 3. Suppression of seizure-like activity in Xrcc1Nes-Cre brain slices by Parp1 deletion.
A Plots of enveloped spike activity waveforms based on targeted extracellular recordings from hippocampal CA3 region perfused into epileptogenic buffer for the
indicated genotypes. Upward deflections indicate seizure-like episodes (SLEs). Scale bars, 5% of maximum amplitude.
B Heatplots of cumulative SLEs: WT (n = 11 slices from three mice), Xrcc1Nes-Cre (n = 12 slices from four mice), Parp1+//Xrcc1Nes-Cre (n = 12 slices from three mice) and
Parp1//Xrcc1Nes-Cre (n = 10 slices from three mice). Each horizontal bar corresponds to one slice with the colour code indicating cumulative SLEs.
C Summary of mean  SEM cumulative SLE counts. The number of replicates was the same as in (B). At the recording endpoint, the total SLE count in
Xrcc1Nes-Cre is significantly higher than both WT and Parp1/ Xrcc1Nes-Cre (Kruskal–Wallis ANOVA, P < 0.0017, * indicates significance with Dunn’s post hoc
comparisons).
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(PARGi), the enzyme primarily responsible for poly(ADP-ribose) cata-
bolism (Fig 5A and B). To confirm that the elevated poly(ADP-ribose)
detected here was nascent polymer resulting from hyperactive Parp1,
rather than pre-existing poly(ADP-ribose), we co-incubated the
neurons with an inhibitor of PARP1 (PARPi). Indeed, the presence of
PARPi ablated the appearance of poly(ADP-ribose) in the Xrcc1Nes-Cre
neurons (Fig 5A and B). This result demonstrates that Parp1 hyperac-
tivation occurs continuously in Xrcc1Nes-Cre hippocampal neurons,
presumably as a result of the elevated steady-state level of unrepaired
SSBs.
Next, to measure presynaptic calcium signalling, we transduced
dissociated hippocampal cultures from different genotypes with
SyGCaMP6f, a presynaptically targeted optical Ca2+ reporter (Fig 6A
and B) (Dreosti et al, 2009). We then carried out time-lapse imaging
at DIV15–17 to assess Ca2+ dynamics in response to electrical
stimulation. We found that with repeated presentations of 10 Hz
stimulus trains, SyGCaMP6f-positive puncta in wild-type mouse
cultures showed characteristic transient increases in fluorescence
consistent with activity-evoked Ca2+ influx at the presynaptic termi-
nal (Fig 6C). Strikingly, however, the amplitude of these responses
was ~ 2-fold higher in Xrcc1Nes-Cre neurons, indicating that Xrcc1
loss results in excessive activity-evoked synaptic Ca2+ influx (Fig 6C
and D). Moreover, this defect was partially or fully suppressed by
deletion of one or both alleles of Parp1, respectively, suggesting that
the excessive activity-evoked synaptic Ca2+ influx was a result of
Parp1 hyperactivity (Fig 6C, E and G). To confirm this, we incu-
bated cultures with PARP1 inhibitor (PARPi) continuously for 9–
11 days prior to recording. Strikingly, this treatment fully
suppressed the aberrant Ca2+ response in Xrcc1Nes-Cre neurons





Figure 4. Suppression of seizure-like activity in Xrcc1Nes-Cre brain slices by PARP1 inhibitor.
A Brightfield image (left) of an acute brain slice positioned on HD-MEA with targeted regions indicated. (Right) progression of a typical seizure event in a slice perfused
with epileptogenic buffer; colour code indicates voltage changes in microvolts.
B Representative traces from four channels in the CA3 region of hippocampus recorded from 10 to 15 min in epileptogenic buffer, showing seizure-like activity in
Xrcc1Nes-Cre. Vertical scale bar indicates 300 lV.
C Mean cumulative activity plots in CA1 and CA3 regions of hippocampus and cortex over 15 min of recording in epileptogenic buffer. WT (n = 8 slices from four mice),
Xrcc1Nes-Cre (n = 9 slices from four mice).
D Summary histograms of the mean ( SEM) cumulative seizure-like activity at 15 min, from the data in panel C. Statistical significance was assessed by ANOVA with
post hoc pairwise comparisons (*P < 0.05).
E Summary histograms (mean  SEM) of cumulative seizure-like activity at 5-, 10- and 15-min timepoints in cortex, CA1 and CA3 regions of wild-type and Xrcc1Nes-Cre
brain slices from mice treated or not for 5–8 days ad libitum with PARP1 inhibitor (ABT-888) prior to analysis. WT (n = 8 slices from four mice), Xrcc1Nes-Cre (n = 10
from five mice), WT + PARPi (n = 6 from three mice) and Xrcc1Nes-Cre + PARPi (n = 9 from three mice). Pairwise comparisons at the 15-min timepoint between WT
versus Xrcc1Nes-Cre mice and WT versus Xrcc1Nes-Cre mice + PARPi were conducted by Kruskal–Wallis with Dunn’s post hoc tests, and statistically significant differences
(*P < 0.05) are shown.
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that aberrant Parp1 activity deregulates synaptic Ca2+ signalling,
providing a compelling explanation for the elevated seizures and,
consequently, shortened lifespan in Xrcc1Nes-Cre mice.
Discussion
DNA single-strand breaks (SSBs) are the commonest DNA lesions
arising in cells and can block the progression of DNA and RNA poly-
merases (Hsiang et al, 1989; Zhou & Doetsch, 1993, 1994; Tsao
et al, 1993; Kathe et al, 2004; Caldecott, 2008; Neil et al, 2012). The
collision of DNA polymerases with SSBs can also result in DNA
replication fork collapse and the formation of DSBs (Ryan et al,
1991; Strumberg et al, 2000; Kuzminov, 2001). However, proliferat-
ing cells possess effective and accurate homologous recombination
mechanisms by which replication-associated DSBs can be repaired
using an intact sister chromatid (Haber, 1999; Arnaudeau et al,
2001; Costes & Lambert, 2012), perhaps explaining why human
diseases in which SSBR is attenuated do not result in markedly
elevated genome instability and cancer (Caldecott, 2008; Yoon &
Caldecott, 2018). Consistent with this idea, proliferating cells from
individuals with genetic defects in SSBR possess elevated levels of
sister chromatid exchange, a hallmark of homologous sister chro-
matid recombination (El-Khamisy et al, 2005; Hoch et al, 2017).
In contrast to proliferating cells, post-mitotic cells lack sister
chromatid recombination and so are more reliant on SSBR, perhaps
explaining why defects in the latter pathway are primarily associ-
ated with neurological dysfunction (McKinnon & Caldecott, 2007;
Caldecott, 2008; Yoon & Caldecott, 2018). In addition, SSBs may
arise in neurons at higher frequencies than other cell types, for
example as a result of glutamate excitotoxicity (Mandir et al, 2000)
and/or as a result of processes associated with gene transcription.
As an example of the latter, topoisomerase I activity can induce
protein-linked SSBs during gene transcription and these have been
implicated previously in SSBR-defective neurodegenerative diseases
(Takashima et al, 2002; El-Khamisy et al, 2005; Katyal et al, 2014;
Kalasova et al, 2020). In addition, the modified base 5’-hydrox-
ymethylcytosine is highly enriched in brain and may generate SSBs
as an obligate intermediate of DNA base excision repair, during
epigenetic reprogramming (Kriaucionis & Heintz, 2009; Li & Liu,
2011).
Arguably the most severe pathology observed in SSBR-defective
disease is neurological seizures. However, the molecular mecha-
nisms by which unrepaired SSBs trigger these potentially lethal
events are unknown. Here, we have identified one such mechanism.
We found that genetic deletion of Parp1 greatly suppressed the
increased seizures in Xrcc1Nes-Cre mice, demonstrating for the first
time a causal impact of excessive/aberrant Parp1 activity on these
events. Consistent with this, we found that poly(ADP-ribose) levels
are elevated across Xrcc1Nes-Cre brain and are particularly high in the
hippocampus, a region of the brain commonly associated with
seizure activity. We also detected elevated levels of poly(ADP-
ribose) in dissociated Xrcc1Nes-Cre hippocampal neurons, which we
confirmed was the result of ongoing Parp activity. The presence of
elevated poly(ADP-ribose) is consistent with the SSBR defect in
Xrcc1Nes-Cre mice, because the synthesis of this polymer is triggered
by endogenous SSBs (Benjamin & Gill, 1980; Ikejima et al, 1990;
Eustermann et al, 2015; Hanzlikova et al, 2018). Nevertheless, that
the level of endogenous poly(ADP-ribose) was high enough to detect
in Xrcc1Nes-Cre brain slices was surprising, and is consistent with the
idea discussed above that SSB levels are particularly elevated in
brain.
A B
Figure 5. Parp1 hyperactivation in isolated Xrcc1Nes-Cre hippocampal neurons.
A Representative images of indirect immunofluorescence of DIV6 hippocampal neurons cultured from P1 WT and Xrcc1Nes-Cre mouse pups, immunostained for ADP-
ribose (red), NeuN to identify neurons (green) and counterstained with DAPI (blue). Cells were pretreated with PARP inhibitor (10 µM) or vehicle for 2 h prior to
fixation, with PARG inhibitor (10 lM) additionally present for the final hour. Scale bar 10 µm.
B Histogram of mean ( SEM) relative pan-ADP-ribose fluorescence in NeuN-positive hippocampal neurons pretreated with PARP inhibitor (5 µM) or vehicle for 5 h
prior to fixation, with PARG inhibitor (10 lM) additionally present for the final hour. Neurons were cultured from WT (n = 6 mice, > 180 cells per condition),
Xrcc1Nes-Cre (n = 6, > 180), Parp1+/-/Xrcc1Nes-Cre (n = 3, > 90) and Parp1//Xrcc1Nes-Cre (n = 3, > 90). * indicates significant differences from WT (Kruskal–Wallis ANOVA,
P = 0.0013 and Dunn’s post hoc tests).
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To our knowledge, these data are the first to demonstrate a
molecular mechanism by which unrepaired DNA strand breaks trig-
ger neurological seizures. Seizures are potentially lethal events,
associated with a condition denoted sudden unexpected death
during epilepsy (SUDEP) (Smithson et al, 2014; Buchhalter &
Cascino, 2017). Indeed, Xrcc1Nes-Cre mice exhibit a dramatically
shorted lifespan, which by video imaging we established here is due
to episodic epilepsy leading ultimately to a fatal seizure. The cause
of death in Xrcc1Nes-Cre mice during seizure is unclear but, similar to
SUDEP, is likely to result from the disruption of normal cardiac or
respiratory function (Glasscock, 2014). The discovery that deletion
of one Parp1 allele prolonged the lifespan of Xrcc1Nes-Cre mice to a
greater extent (~25-fold) than did deletion of both Parp1 alleles (~ 7-
fold) is surprising. This indicates that whilst loss of one allele of
Parp1 is sufficient to suppress Parp1-induced lethality, additional
loss of the second allele eradicates an as yet unidentified role for
Parp1 in Xrcc1-defective brain that is important for long-term
survival. This role likely involves the signalling and/or processing
of SSBs, because it is required for longevity only in the absence of
Xrcc1. The cause of the shortened lifespan in Xrcc1Nes-Cre mice lack-
ing both Parp1 alleles is unclear, but is unlikely to involve seizures
because we failed to detect elevated seizure-like activity in brain
sections from these mice, ex vivo.
PARP1 hyperactivity can trigger cell death via excessive deple-
tion of NAD+, inhibition of glycolysis, and/or by a specialized type
of apoptosis known as parthanatos (Zhang et al, 1994; Eliasson
et al, 1997; Andrabi et al, 2006; Yu et al, 2006; Aredia & Scovassi,





Figure 6. Aberrant presynaptic calcium signalling in Xrcc1/ hippocampal neurons is rescued by Parp1 deletion or inhibition.
A Representative image of DIV15 dissociated cultured neurons used. Scale bar: 100 µm.
B (Top) Cartoon schematic illustrates SyGCaMP6f targeting and action. (Bottom) Image shows typical punctate SyGCaMP6f expression at DIV15. Scale bar, 20 µm.
C Representative images of fluorescence responses in synaptic terminals expressing SyGCaMP6f to a train of 10 stimuli at 10 Hz in dissociated hippocampal neurons
derived from wild-type and mutant mice. Scale bar: 5 µm.
D, E Mean SyGCaMP6f responses to three rounds of 10 action potentials stimulation from mice of the following genotypes: WT (n = 1,946 synapses, nine coverslips,
three animals), Xrcc1Nes-Cre (n = 3,313, 12, 4), Parp1+//Xrcc1Nes-Cre (n = 2,272, 9, 3) and Parp1//Xrcc1Nes-Cre (n = 2,122, 11, 3).
F Response to chronic treatment with the PARP inhibitor, KU 0058948 Hydrochloride (1 µM) for 9–11 days prior to imaging for Xrcc1+/+ (n = 1,264 synapses, eight
coverslips, three animals) and Xrcc1Nes-Cre (n = 2,231, 10, 4) mice.
G Summary histogram of the mean ( SEM) of the integrated fluorescence responses for all individual synapses for each condition. Synapse number is the same as in
(D–F). Responses are significantly higher in Xrcc1Nes-Cre synapses versus bothWT and Parp1//Xrcc1Nes-Cre (one-way ANOVA, *P < 0.0033 and pairwise Student’s t-tests).
Data information: (D–F) Data are from three or more independent experiments per genotype/treatment type, combined into one experimental data set and plotted on
three separate graphs for clarity. Dashed lines in panels E and F are the WT and/or Xrcc1Nes-Cre curves transposed from panel D for comparative purposes.
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Parp1 activity resulted in aberrant Ca2+ signalling at presynaptic
terminals in viable neurons in culture suggests that Parp1 impacts
on synaptic function, directly. It will now be important to identify
how Parp1 hyperactivity leads to deregulated calcium homeostasis
and to understand the downstream consequences of this deregula-
tion on the propagation of information through neural circuits. It is
possible that Parp1 hyperactivity affects Ca2+ signalling, in part at
least, as a result of NAD+ depletion. Consistent with this possibility,
we discovered in the current work that NAD+ levels are reduced
by ~ 50% in Xrcc1Nes-Cre brain. This is because this enzyme co-
factor is required for the synthesis of several second messengers
involved in calcium mobilization and release (Guse, 2015). In addi-
tion, reduced levels of NAD+ can affect the expression of genes
encoding regulators of calcium homeostasis, as has been reported in
the neurodegenerative disease spinocerebellar ataxia type 7 (Stoyas
et al, 2019). Alternatively, or in addition, Parp1 hyperactivity might
deregulate calcium signalling more directly, via inappropriate ADP-
ribosylation of itself or other proteins that regulate gene expression,
for example.
It is worth noting that the defects reported here in Parp1 hyperac-
tivity, NAD+ levels and calcium signalling likely extend beyond the
hippocampus and seizure phenotypes to other neurological patholo-
gies. Indeed, we have shown previously that Parp1 hyperactivation
accounts for the cerebellar dysfunction and ataxia that is observed
in Xrcc1Nes-Cre mice (Hoch et al, 2017). It will now be of interest to
investigate the impact of NAD+ depletion and/or deregulated
calcium homeostasis on these pathologies too. In addition, although
speculative, our data may also be relevant to other ageing-related
neurodegenerative conditions, and perhaps even normal human
ageing, in which altered levels of PARP1 activity, NAD+ metabolism
and calcium homeostasis are features (Maynard et al, 2015; Stoyas
et al, 2019).
Finally, it is also noteworthy that we were able to ablate the
elevated seizure-like activity in Xrcc1-defective hippocampal slices
by chronic application of PARP inhibitor in the drinking water of
the mother. This is an exciting finding, because it supports the
possibility that PARP inhibition might provide a therapeutic
approach for the treatment of XRCC1-defective, and possibly other,
neurological diseases. It should be noted however that currently
available inhibitors may not be suitable for this purpose, however,
because they “trap” PARP enzymes on unrepaired SSBs and so exac-
erbate DNA repair defects, thereby increasing DNA replication fork
stalling and/or collapse during S phase. Whilst this is not a problem
for post-mitotic neurons, proliferating XRCC1-defective cells are
hypersensitive to inhibitors that trap PARP1 (Ali et al, 2018, 2020).
Although the PARP inhibitor employed here for our in vivo experi-
ments (ABT-888; Veliparib) is a relatively weak “trapper” (Murai
et al, 2012), this may explain why we have so far been unable to
extend significantly the lifespan of XRCC1Nes-Cre mice by PARP inhi-
bition.
In summary, we reveal here that aberrant Parp1 activity triggers
seizures and shortened lifespan in Xrcc1Nes-Cre mice. We demon-
strate seizure-like activity in Xrcc1-defective hippocampus ex vivo
and aberrant presynaptic Ca2+ signalling in hippocampal neurons
in vitro, and we show that these defects are suppressed by Parp1
deletion or inhibition. These data highlight Parp1 inhibition as a
possible therapeutic approach for the treatment of XRCC1-defective
neurological disease.
Materials and Methods
Animals and animal care
Experiments were carried out in accordance with the UK Animal
(Scientific Procedures) Act 1986 and satisfied local institutional
regulations at the University of Sussex. Mice were maintained and
used under the auspices of UK Home Office project licence number
P3CDBCBA8. The generation of Parp1/, Xrcc1Nes-Cre and Ku70/
mice was reported previously (Wang et al, 1995; Lee et al, 2009).
Intercrosses between Parp1/ and Xrcc1+/loxp mice were main-
tained in a mixed background C57Bl/6 × S129 strain and housed on
a 12 -h light/dark cycle with lights on at 07:00. Temperature and
humidity were maintained at 21°C ( 2°C) and 50% ( 10%),
respectively. All experiments were performed under the UK Animal
(Experimental Procedures) Act, 1986.
Antibodies
Antibodies used were mouse monoclonal anti-PARP1 (Serotec;
MCA1522G), rabbit Fc-fused anti-poly-ADP-ribose binding reagent
(Millipore; MABE1031), rabbit Fc-fused anti-pan-ADP-ribose binding
reagent (Millipore; MABE1016), rabbit polyclonal anti-poly-ADP-
ribose (Trevigen; 4336), rabbit monoclonal anti-ATM [EPR17059]
(Abcam; ab199726), mouse monoclonal anti-NeuN (A60, Milli-
pore; MAB337), rabbit polyclonal anti-XRCC1 (Novus Biologicals;
NBP1-87154) and rat polyclonal anti-a-tubulin (YL1/2, Abcam;
ab6160). Secondary antibodies used for immunofluorescence were
goat anti-rabbit Alexa 647 and anti-mouse Alexa 488 (Invitrogen; A21244
and A11001) and for immunohistochemistry Biotin-SP-conjugated Affini-
Pure goat anti-rabbit antibody (Jackson ImmunoResearch; 111-065-144).
Immunohistochemistry and microscopy
Mice were anaesthetized using 0.25 mg/g Dolethal (Vetoquinol UK
Ltd) and perfused transcardially with PBS followed by 4% formalde-
hyde. Brains were postfixed in 4% paraformaldehyde for 48 h and
stored in 25% sucrose/PBS until moulding and freezing (TFM-5).
10–20 lm sagittal sections were prepared using a cryostat (Leica
CM1850). Immunohistochemistry was conducted as described previ-
ously (Hoch et al, 2017). Fluorescent images were acquired using
the Zeiss LSM880 confocal microscope, with oil immersion objective
(Plan-Apochromat 63×/1.4 Oil DIC M27). The Airyscan super-
resolution module was used to obtain high-resolution images. The
image stacks were processed for brightness and contrast in ImageJ
1.51j. Images of immunohistochemistry samples were acquired with
LSM880 using the wide-field imaging mode (Axiocam 503 Mono,
Plan-Apochromat 10×/0.45 and 20×/0.8 M27). Nuclear staining was
quantified manually using ImageJ 1.51j. The mean nuclear signal
was normalized by subtracting the mean value for background
staining. Whole tissue sections were imaged in a tiling mode with
10% overlap and stitched in Zeiss Zen.
ADP-ribosylation assay and Western blotting
Mouse brains were dissected from P15 mouse pups following cervi-
cal dislocation. The cerebellum and the forebrain containing cortex
and hippocampus were isolated separately. The frozen tissues were
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processed in glass Dounce homogenizer on ice in lysis buffer
containing 20 mM HEPES pH 7.4, 2 mM EGTA, 1 mM DTT, 1 % v/v
Triton X-100, 10% v/v glycerol, 1× protease inhibitor cocktail
(Roche cOmplete, EDTA-free) and 1% v/v phosphatase inhibitor
cocktail (Sigma 003). After 15 min on ice with occasional swirling,
unbroken cells were removed at 500 g in a cooled centrifuge for
10 min. The salt concentration of the supernatant was adjusted to
100 mM KCl, 2.5 mM MgCl2, and protein concentration determined
using the BCA assay (Pierce). For the ADP-ribosylation assay,
DMSO or 10µM PARPi (KU0058948 hydrochloride, Axon) as indi-
cated was combined with the tissue lysates 15 min prior to initiation
of the reaction by addition of 1 mM b-Nicotinamide adenine dinu-
cleotide (NAD+, NEB). Aliquots of each reaction were stopped after
5, 10, 15, 30 and 45 min in 5× Laemmli buffer (2.5 mM Tris–HCl pH
6.8, 0.5 mM DTT, 1% SDS, 50% glycerol, 0.05% Bromophenol
blue). The samples were subjected to SDS–PAGE (7 or 10%),
proteins transferred onto nitrocellulose membrane and detected
using the poly(ADP-ribose)-specific detection reagent MABE1031,
combined with horseradish peroxidase-conjugated secondary anti-
bodies. Peroxidase activity was detected by ECL reagent (ClarityTM
Western ECL Substrate, Bio-Rad) and Medical X-ray Film Blue (Agfa
HealthCare).
NAD+ assay
NAD+ levels in mice brain tissue were determined by a chro-
mogenic assay as described before (Baker et al, 2016). Briefly, fore-
brain tissue containing cortex and hippocampus was dissected from
P15 mice. The tissue was washed in PBS and homogenized in lysis
buffer [20 mM sodium bicarbonate, 100 mM sodium carbonate,
0.5% Triton X-100, 10 mM nicotinamide, 100 lM PARG inhibitor
(PDD00017273, Sigma), 40 lM PARP inhibitor (KU0058948, Axon)
and cOmplete protease inhibitors (04693132001, Roche), pH 10.3]
using TissueLyser II (Qiagen). The cells were further lysed by two
freeze/thaw cycles. Proteins concentrations were measured in
samples after centrifugation and normalized, and the lysates then
added to a 10,000 MWCO centrifugal filter (UFC501024, MerckTM)
and centrifuged at 14,000 g at 4°C for 30 min. Half of each lysate
was incubated at 60°C for 30 min to decompose NAD+. Samples
were incubated in cycling buffer [100 mM tricine-NaOH (pH 8),
4 mM EDTA, 40 mM NaCl, 1.66 mM phenazine ethosulfate (PES),
0.42 mM thiazolyl blue tetrazolium bromide (MTT), 10% ethanol]
at 37°C for 5 min, and 10 U/ml alcohol dehydrogenase, reconsti-
tuted in 100 mM tricine-NaOH (pH 8), was added to drive a cycling
reaction at 37°C for 40 min. The reaction was terminated by addi-
tion of NaCl (2 M final concentration), and samples were centri-
fuged at 10,000 g at 4°C for 5 min. Reduced MTT was resuspended
in 100% ethanol, and the absorbance was measured at 560 nm.
NAD+ concentrations were calculated by subtracting the NADH
concentration in the sample in which NAD+ was decomposed prior
to the cycling reaction from that which was not.
Electrophysiology
For targeted extracellular recordings, acute transverse hippocampal
slices (300 µm) were prepared from P14-P16 mice using a vibro-
slicer (VT1200S, Leica Microsystems, Germany) in ice-cold artificial
cerebrospinal fluid containing (in mM): 125 NaCl, 2.5 KCl, 25
glucose, 1.25 NaH2PO4, 26 NaHCO3, 1 MgCl2, 2 CaCl2 (bubbled with
95% O2 and 5% CO2, pH 7.3). All experiments were performed at
23–25°C. During an experiment, an extracellular electrode was
placed in the hippocampal CA3 pyramidal region and field voltage
recordings made as slices were perfused from ACSF into a modified
(epileptogenic) saline containing (in mM) 125 NaCl, 5 KCl, 25
glucose, 1.25 NaH2PO4, 26 NaHCO3, 2 CaCl2. Signals were amplified
using a MultiClamp 700A (Molecular Devices), digitized at 50 kHz
with a Digidata 1320 and recorded in pCLAMP acquisition software
(Molecular Devices) for offline analysis. To quantify seizure-like
activity, raw traces were exported and analysed in MATLAB (Math-
Works). Root mean square signal envelopes (sliding window length:
400 samples) were calculated for each trace and a peak waveform
generated using an automated peak-find search function. This wave-
form was then enveloped (sliding window length: 1,500 samples)
and a peak count analysis used to quantify seizure-like episodes
(SLEs) for each sample. To independently verify our automated
analysis approach, we also carried out a separate manual count of
SLEs, by tallying episodes in 2.5 s time bins. Outputs from both
types of quantification were highly significantly positively correlated
(Spearman rank, rs = 0.833, P < 0.0001).
For MEA recordings, slices were placed onto a high-density Stim-
ulo MEA chip (4096 electrodes: size 21 × 21 µm, pitch 81 µm,
64 × 64 matrix, 3Brain). The slices were immobilized using a custom-
made weight under membrane and were constantly perfused with
oxygenated (epileptogenic) ACSF (as above) at + 34C. Recordings
were acquired with BrainWave v4.2 software in 10-min time
windows, digitized at 9.5 kHz and stored for offline analysis. 7-chan-
nel arrays from target regions were batch-exported in 3Brain HDF5
format and quantified in MATLAB. Signals were processed first by
enveloping (RMS signal envelope, sliding window length: 500
samples) and then by generating a peak waveform to identify
seizure-like events. These waveforms were then integrated to
provide a collective measure of burst frequency and amplitude at
each timepoint and presented as cumulative totals. Where indi-
cated, the PARP inhibitor ABT-888 Hydrochloride (Selleckchem)
was administered in drinking water (250 µg/ml, ad libitum) to the
mouse dam and pre-weaned pups from their post-natal day 10
(P10) until analysis at P14–17.
Video analysis
Video monitoring was performed using the Noldus PhenoTyper
3000 system, including infrared LED units and a video recording
camera for the duration of the experiment [video output CCIR
black/white VPP 75 Ohm (PAL) or EIA black/white Vpp-75 Ohm
(NTSC)]. Mice were placed in the chamber with floor area
30 cm × 30 cm and were provided with bedding, minimal nesting,
food pellets and a water source. Mouse pups of the indicated geno-
type were housed with mother and a control sibling from P15 up to
P20. Video recordings were observed after recording, and the
number of running–bouncing seizures was quantified.
Cell culture
P1–2 mouse pups were decapitated, and brains were removed and
placed in ice-cold Hank’s buffered saline solution (HBSS), 0.1 M
HEPES. Hippocampi were isolated and then washed three times in
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warmed 10% FCS, 20 mM glucose and 1% Pen/Strep Minimal
Essential Media (MEM) (Gibco). Hippocampi were manually disso-
ciated by trituration and diluted to a density of 50,000 cells/well
and plated on poly-D-Lysine (20 µg/ml) coated 15-mm glass cover-
slips. 2 h after plating, the media was replaced with 2% B27, 1%
glutamax and 1% Pen/Strep-supplemented neurobasal A medium
(Gibco). Cells were maintained without cytosine arabinoside,
typically used to manage glial cell count, to prevent induction of
exogenous DNA damage (Zhuo et al, 2018). Cells were maintained
in 5% CO2 at 37°C and fed every 3 days through half-exchange of
media. Hippocampal cells were taken for ICC experiments at DIV6
and live imaging at DIV15–17. Hippocampal cells treated for PAN
immunofluorescence were administered 10 µM PARG inhibitor PDD
00017273 (Tocris) in DMSO for 1 h following pre-treatment with
5 µM PARPi Ku-0058948 or DMSO vehicle. Cells were fixed in 4%
paraformaldehyde and permeabilized with 0.2% Triton X-100 for
2 min. Cells were blocked in 10% goat serum and 0.3% Triton X-
100 for 30 min prior to incubation with relevant primary antibodies.
Cells were incubated with relevant secondary antibodies following
PBST washes and counterstained with DAPI prior to mounting.
SyGCaMP6f imaging
Hippocampal neurons were transduced with AAV6_SyGCaMP6f at
DIV6/7 at a multiplicity of infection (MOI) of 100. Images were
acquired using a 60×/1.0 NA objective on an Olympus BX61WI micro-
scope fitted with an Andor Ixon + EM-CCD (40 ms exposure, 20 Hz
acquisition frequency and 4 × 4 binning) controlled by custom-
written Micromanager routines. Coverslips were placed in a custom-
built imaging chamber, and a Grass SD9 Stimulator was used to apply
field stimulation (voltage: 22.5V, 1 ms pulse width). All experiments
were carried out in Extracellular Bath Solution (EBS) containing (in
mM), 136 NaCl, 10 HEPES, 10 D-Glucose, 2.5 KCl, 2 CaCl2 and 1.3
MgCl2. EBS was supplemented with 50 µM APV and 20 µM CNQX to
inhibit NMDA and AMPA receptors, respectively. Image stacks were
analysed using IGOR Pro 8. Stacks were imported via the SARFIA
plugin (Dorostkar et al, 2010) and corrected for x-y drift using the
built-in image registration function (Thevenaz & Unser, 1998).
Regions of Interest (ROIs) were detected via image segmentation using
a threshold of (3) × SD of all pixel values in the Laplace operator.
Mean background intensity was subtracted to account for alterations
to background fluorescence, and DF/F values were calculated using
the 10 frames prior to stimulation as a baseline. A custom script was
used to determine whether ROIs had exceeded a threshold change in
fluorescence intensity following stimulation and ROIs that failed to
reach threshold intensity were removed from the mask.
Data availability
No large-scale datasets are associated with this work. All raw data
and materials associated with the figures are available on request.
Expanded View for this article is available online.
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